Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Urinary Bladder Neoplasms × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Carcinoma, Hepatocellular 5 Pancreatic Neoplasms 4 Liver Neoplasms 4 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Cholangiocarcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Diseases 1 Laryngeal Neoplasms 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Extremities Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Bile Duct Neoplasms 1

Interventions

Standard of Care 8 Cystectomy 8 Early Intervention, Educational 6 Cystoscopy 6 Transurethral Resection of Bladder 4 Practice Guidelines as Topic 4 Multiparametric Magnetic Resonance Imaging 4 Methods 4 Blood Specimen Collection 4 Anesthesia, General 4 Surgical Procedures, Operative 3 Sevoflurane 3 Radiotherapy, Intensity-Modulated 3 Gemcitabine 3 Exercise 3 Cisplatin 3 Anesthesia, Spinal 3 Watchful Waiting 2 Specimen Handling 2 Saline Solution 2 Robotic Surgical Procedures 2 Radiotherapy 2 Psychiatric Rehabilitation 2 Propofol 2 Preoperative Exercise 2 Palliative Care 2 Optical Imaging 2 Neoadjuvant Therapy 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430623 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡